Answers are grounded in this paper and cite their sources.
Despite the effectiveness of antiretroviral therapy (ART), chronic immune activation and inflammation persist in people living with HIV (PLWH), with monocytes and macrophages playing a key role in viral persistence and immune dysregulation. Recent research has identified metabolic remodeling in these cells, characterized by enhanced glucose utilization, mitochondrial and redox dysfunction, and impaired cholesterol homeostasis. These changes, alongside alterations in DNA methylation, chromatin accessibility, and transcription, modulate inflammatory and antimicrobial functions, often persisting beyond the initial stimulus. In this minireview, we summarize the current evidence on the metabolic, epigenomic, and transcriptional reprogramming of monocytes and macrophages during HIV infection and ART. We further examine whether metabolic remodeling contributes to persistent myeloid phenotypes through epigenomic mechanisms. Although direct evidence linking these processes remains limited, data from studies involving Nef-containing extracellular vesicles is promising. Further integrated and longitudinal studies are required to establish causality and elucidate the mechanisms connecting metabolic and epigenomic remodeling in HIV.
No takes yet. Share an insight, caveat, or question.
Kimura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: